A Placebo-Controlled, Blinded and Randomised Study on the Effects of Recombinant Human Thyrotropin on Quality of Life in the Treatment of Thyroid Cancer

Publisher： Karger

E-ISSN： 2235-0802|2|3|195-202

ISSN： 2235-0640

Source： European Thyroid Journal, Vol.2, Iss.3, 2013-09, pp. : 195-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Recombinant Human Thyrotropin on Heart Rate Variability and Blood Pressure in Patients on l-Thyroxine-Suppressive Therapy for Differentiated Thyroid Carcinoma

By  

Hormone Research in Paediatrics, Vol. 64, Iss. 2, 2005-10 ,pp. : 100-106

Karger

Access to resources Recommend Favorite

Recombinant Human Thyroid-Stimulating Hormone: Use in Papillary and Follicular Thyroid Cancer

By  

Hormone Research in Paediatrics, Vol. 67, Iss. 1, 2007-02 ,pp. : 132-142

Karger

Access to resources Recommend Favorite

Recombinant Human Thyrotropin Use Resulting in Ovarian Hyperstimulation: An Unusual Side Effect

By  

European Thyroid Journal, Vol. 3, Iss. 2, 2014-06 ,pp. : 125-129

Karger

Access to resources Recommend Favorite

Total Thyroidectomy for Thyroid Cancer Followed by Thyroid Storm due to Thyrotropin Receptor Antibody Stimulation of Metastatic Thyroid Tissue

By  

European Thyroid Journal, Vol. 6, Iss. 5, 2017-08 ,pp. : 276-280

Karger

Access to resources Recommend Favorite

Beneficial Effect of Growth Hormone Treatment on Health-Related Quality of Life in Children with Prader-Willi Syndrome: A Randomized Controlled Trial and Longitudinal Study

By  

Hormone Research in Paediatrics, Vol. 84, Iss. 4, 2015-0 ,pp. : 231-239

Karger

Access to resources Recommend Favorite